Bone Marrow TransplantationBone MarrowTransplantation, HomologousBone Marrow CellsExchange Transfusion, Whole BloodGraft vs Host DiseaseTissue DonorsBlood DonorsTransplantation, AutologousWhole-Body IrradiationBlood TransfusionHistocompatibility TestingHematopoietic Stem Cell TransplantationAnemia, AplasticLiver TransplantationTransplantation ConditioningHistocompatibilityLeukemiaGraft SurvivalTransplantation ChimeraKidney TransplantationHematopoietic Stem CellsBone Marrow PurgingBusulfanBone and BonesABO Blood-Group SystemTransplantation, IsogeneicBone Marrow DiseasesCyclophosphamideGraft RejectionRecurrenceLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Host ReactionHLA AntigensHematopoiesisTreatment OutcomeHematologic NeoplasmsLeukocyte TransfusionBone Marrow ExaminationTime FactorsRadiation ChimeraMice, Inbred C57BLHeart TransplantationImmunosuppressionCombined Modality TherapyImmunosuppressive AgentsLiving DonorsStem Cell TransplantationLeukemia, Myeloid, AcuteTransplantation ImmunologyTissue and Organ ProcurementBone Marrow NeoplasmsAcute DiseaseRemission InductionLung TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseRetrospective StudiesSurvival AnalysisLeukemia, MyeloidT-LymphocytesLymphocyte DepletionColony-Forming Units AssayLymphoma, Non-HodgkinOrgan TransplantationCord Blood Stem Cell TransplantationBloodMyelodysplastic SyndromesChimeraSevere Combined ImmunodeficiencyCyclosporineSurvival RateHematologic DiseasesActuarial AnalysisDisease-Free SurvivalLymphocyte TransfusionCell DifferentiationAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesNuclear FamilyPancytopeniaCarmustineSpleenGraft vs Tumor EffectCell TransplantationLeukocyte CountCytomegalovirus InfectionsGranulocyte Colony-Stimulating FactorPancreas TransplantationCytarabineGraft vs Leukemia EffectBone RemodelingIslets of Langerhans TransplantationMice, Inbred BALB CFlow CytometryMelphalanMultiple MyelomaTransplantationCells, CulturedLymphoma